Masco’s New US$2 Billion Buyback and Dividend Hike Might Change The Case For Investing In Masco (MAS)
Masco Corporation MAS | 59.12 | -2.59% |
- In the past week, Masco Corporation reported its 2025 fourth-quarter and full-year results, showing slightly lower sales and net income year over year, while also recording a US$5 million impairment on other intangible assets.
- Alongside these results, Masco outlined 2026 guidance, raised its quarterly dividend to US$0.32, completed a sizeable prior buyback, and authorized a new US$2.00 billion repurchase program focused on shareholder returns and selective bolt-on acquisitions in plumbing, wellness, and coatings.
- Against this backdrop, we'll examine how Masco's new US$2.00 billion share repurchase authorization could reshape the company's investment narrative.
AI is about to change healthcare. These 25 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
Masco Investment Narrative Recap
To own Masco today, you need to believe that steady repair and remodel demand, plus higher value plumbing and coatings, can offset softer DIY trends and housing turnover. The latest results, with slightly lower sales and net income and a small US$5 million impairment, do not appear to change that core thesis, but they keep near term demand softness and margin pressure as the key risk to watch.
The new US$2.00 billion share repurchase authorization is the clearest link to the current catalyst: capital returns. It follows the completion of a prior US$1.67 billion program and sits alongside 2026 guidance for roughly flat to low single digit sales growth, suggesting that, for now, reducing the share count and pairing it with selective bolt on acquisitions is a central part of how Masco is trying to support earnings per share.
Yet, despite the new buyback, investors should be aware that prolonged weakness in DIY demand and home turnover could still...
Masco’s narrative projects $8.7 billion revenue and $1.1 billion earnings by 2028. This requires 4.2% yearly revenue growth and a roughly $295 million earnings increase from $805.0 million today.
Uncover how Masco's forecasts yield a $74.37 fair value, in line with its current price.
Exploring Other Perspectives
Before this news, the most optimistic analysts were counting on earnings rising to about US$1.1 billion by 2028, but if North America slows harder than expected, that bullish margin story may look very different, so it is worth comparing how your view lines up with those stronger growth assumptions.
Explore 5 other fair value estimates on Masco - why the stock might be worth less than half the current price!
Build Your Own Masco Narrative
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
- A great starting point for your Masco research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.
- Our free Masco research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Masco's overall financial health at a glance.
Interested In Other Possibilities?
Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:
- The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 26 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
- Find 53 companies with promising cash flow potential yet trading below their fair value.
- The latest GPUs need a type of rare earth metal called Terbium and there are only 30 companies in the world exploring or producing it. Find the list for free.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
